A bill that exempts those caring for the terminally ill from checking the Prescription Drug Monitoring Program (PDMP) was passed (9-0) by the Senate Health and Human Services Committee. The PDMP was established in 2009 as a registry to assist law enforcement in reducing abuse of prescription drugs. Its use became mandatory last year, and an unintended consequence was a significant burden placed on those requiring end-of-life care. Experience has shown the terminally ill do not engage in drug seeking among multiple physicians. SB 592 would simplify the process of care for these terminal patients.
Marco Paredes, FCCB associate director for health, testified in support of the bill at the committee hearing. The FCCB strongly opposes both opioid abuse and assisted suicide. The best defense against the encroachment of assisted suicide is quality end-of-life care, including effective pain management.